Risk factors and management experiences of stent valves detachment in transcatheter aortic valve implantation (TAVI)_Chinese Journal of Clinical Thoracic and Cardiovascular Surgery

Authors：

LI Yuehuan ¹ , MENG Xu ¹ , ZHOU Yujie ² , LIU Wei ² , ZHU Zhihui ¹ , LIU Kun ¹ , ZHANG Han ³ , WANG Shengxun ¹ ,  ZHANG Haibo ¹

1. Department of Cardiac Surgery, Beijing Anzhen Hospital, Capital Medical University, Beijing, 100029, P.R.China;
2. Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, 100029, P.R.China;
3. Department of Echocardiography, Beijing Anzhen Hospital, Capital Medical University, Beijing, 100029, P.R.China;

Corresponding?author：

ZHANG Haibo, Email: zhanghb2318@163.com

Keywords：

Transcatheter arotic valve implantation; aortic stenosis; aortic regurgitation; treatment

DOI：

10.7507/1007-4848.201910027

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Objective To summarize and analyze the risk factors and management of artificial valve slippage in transcatheter aortic valve implantation (TAVI).Methods We retrospectively analyzed the clinical data of 131 patients undergoing TAVI surgery in our center from September 2017 to May 2019, including 62 patients through transapical approach and 69 patients through transfemoral artery approach.Results A total of 131 patients received TAVI surgery, among whom 4 patients had slipped during the operation, 2 patients via transfemoral artery approach, and another 2 patients via transapical. The average age was 77±9 years with one female (25%). Preoperative evaluation, higher position and poor coaxial were main risk factors for valve slip in TAVI.Conclusion Valve slippage is also a serious complication in TAVI surgery. Reasonable and effective treatment can avoid thoracotomy.

Citation： LI Yuehuan, MENG Xu, ZHOU Yujie, LIU Wei, ZHU Zhihui, LIU Kun, ZHANG Han, WANG Shengxun, ZHANG Haibo. Risk factors and management experiences of stent valves detachment in transcatheter aortic valve implantation (TAVI). Chinese Journal of Clinical Thoracic and Cardiovascular Surgery, 2020, 27(7): 807-812. doi: 10.7507/1007-4848.201910027 Copy

1.	Cribier A, Eltchaninoff H, Bash A, et al. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation, 2002, 106(24): 3006-3008.
2.	Liu Z, Kidney E, Bem D, et al. Transcatheter aortic valve implantation for aortic stenosis in high surgical risk patients: A systematic review and meta-analysis. PLoS One, 2018, 13(5): e0196877.
3.	Elmaraezy A, Ismail A, Abushouk AI, et al. Efficacy and safety of transcatheter aortic valve replacement in aortic stenosis patients at low to moderate surgical risk: a comprehensive meta-analysis. BMC Cardiovasc Disord, 2017, 17(1): 234.
4.	Frerker C, Baldus S, Nitschmann S. Transcatheter aortic valve replacement: PARTNER 3 trial and Evolut Low Risk Trial. Internist (Berl) 2019, 60(11): 1221-1224.
5.	Thielmann M, Tsagakis K, El Gabry M, et al. Transcatheter aortic valve implantation (TAVI) in patients with aortic regurgitation. Ann Cardiothorac Surg, 2017, 6(5): 558-560.
6.	Arias EA, Bhan A, Lim ZY, et al. TAVI for pure native aortic regurgitation: Are we there yet? Interv Cardiol, 2019, 14(1): 26-30.
7.	Phan K, Wong S, Phan S, et al. Transcatheter aortic valve implantation (TAVI) in patients with bicuspid aortic valve stenosis—Systematic review and meta-analysis. Heart Lung Circ, 2015, 24(7): 649-659.
8.	Das R, Puri R. Transcatheter treatment of bicuspid aortic valve disease: Imaging and interventional considerations. Front Cardiovasc Med, 2018, 5: 91.
9.	Ussia GP, Barbanti M, Sarkar K, et al. Transcatheter aortic bioprosthesis dislocation: technical aspects and midterm follow-up. EuroIntervention, 2012, 7(11): 1285-1292.
10.	Nishimura RA, Otto CM, Bonow RO, et al. 2017 AHA/ACC focused update of the 2014 AHA/ACC Guideline for the management of patients with valvular heart disease: A report of the American College of Cardiology/American Heart Association Task Force on clinical practice guidelines. J Am Coll Cardiol, 2017, 70(2): 252-289.
11.	中華醫學會心血管病學分會結構性心臟病學組. 中國經導管主動脈瓣置換術臨床路徑專家共識. 中國介入心臟病學雜志, 2018, 26(12): 661-668.

1. Cribier A, Eltchaninoff H, Bash A, et al. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation, 2002, 106(24): 3006-3008.
2. Liu Z, Kidney E, Bem D, et al. Transcatheter aortic valve implantation for aortic stenosis in high surgical risk patients: A systematic review and meta-analysis. PLoS One, 2018, 13(5): e0196877.
3. Elmaraezy A, Ismail A, Abushouk AI, et al. Efficacy and safety of transcatheter aortic valve replacement in aortic stenosis patients at low to moderate surgical risk: a comprehensive meta-analysis. BMC Cardiovasc Disord, 2017, 17(1): 234.
4. Frerker C, Baldus S, Nitschmann S. Transcatheter aortic valve replacement: PARTNER 3 trial and Evolut Low Risk Trial. Internist (Berl) 2019, 60(11): 1221-1224.
5. Thielmann M, Tsagakis K, El Gabry M, et al. Transcatheter aortic valve implantation (TAVI) in patients with aortic regurgitation. Ann Cardiothorac Surg, 2017, 6(5): 558-560.
6. Arias EA, Bhan A, Lim ZY, et al. TAVI for pure native aortic regurgitation: Are we there yet? Interv Cardiol, 2019, 14(1): 26-30.
7. Phan K, Wong S, Phan S, et al. Transcatheter aortic valve implantation (TAVI) in patients with bicuspid aortic valve stenosis—Systematic review and meta-analysis. Heart Lung Circ, 2015, 24(7): 649-659.
8. Das R, Puri R. Transcatheter treatment of bicuspid aortic valve disease: Imaging and interventional considerations. Front Cardiovasc Med, 2018, 5: 91.
9. Ussia GP, Barbanti M, Sarkar K, et al. Transcatheter aortic bioprosthesis dislocation: technical aspects and midterm follow-up. EuroIntervention, 2012, 7(11): 1285-1292.
10. Nishimura RA, Otto CM, Bonow RO, et al. 2017 AHA/ACC focused update of the 2014 AHA/ACC Guideline for the management of patients with valvular heart disease: A report of the American College of Cardiology/American Heart Association Task Force on clinical practice guidelines. J Am Coll Cardiol, 2017, 70(2): 252-289.
11. 中華醫學會心血管病學分會結構性心臟病學組. 中國經導管主動脈瓣置換術臨床路徑專家共識. 中國介入心臟病學雜志, 2018, 26(12): 661-668.

Chinese Journal of Clinical Thoracic and Cardiovascular Surgery

Risk factors and management experiences of stent valves detachment in transcatheter aortic valve implantation (TAVI)

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content